| Field | Row 1 |
|---|---|
| adsh | 0001437749-25-015565 |
| cik | 1625101 |
| name | PULSE BIOSCIENCES, INC. |
| sic | 3841 |
| countryba | US |
| stprba | CA |
| cityba | HAYWARD |
| zipba | 94545 |
| bas1 | 3957 POINT EDEN WAY |
| bas2 | |
| baph | 510-906-4600 |
| countryma | US |
| stprma | CA |
| cityma | HAYWARD |
| zipma | 94545 |
| mas1 | 3957 POINT EDEN WAY |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 465696597 |
| former | PULSE BIOSCIENCES, INC. |
| changed | 20151210 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 17:24:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | plse20250331_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-015565 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Additional Paid In Capital Common Stock | 505296000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1759000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Property Plant And Equipment Net | 1062000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5681000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5681000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 13000.0000 | USD | 1 | us-gaap/2025 | Class Of Warrant Or Right= Rights Offering Warrants; | ||
| 0001437749-25-015565 | 20250331 | Assets | 133383000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 119279000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -9480000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Common Stock Shares Issued | 67274000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Comprehensive Income Net Of Tax | -10137000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Goodwill | 2791000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Operating Lease Right Of Use Asset | -216000.0000 | USD | 1 | 0001437749-25-015565 | |||
| 0001437749-25-015565 | 20250331 | Liabilities | 14931000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Income Loss | -10137000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Income Loss | -16795000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20241231 | Operating Lease Right Of Use Asset | 7163000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Payments To Acquire Property Plant And Equipment | 5000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Proceeds From Stock Options Exercised | 9000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20231231 | Shares Outstanding | 55144000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20241231 | Shares Outstanding | 65926000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20231231 | Stockholders Equity | 55000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20241231 | Stockholders Equity | 505296000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 1 | us-gaap/2025 | Award Type= Marketbased Options; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 296000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Exercise Of Warrants | 13971000.0000 | USD | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 9000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20240331 | Share Based Compensation | 1759000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Accounts Payable Current | 2370000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Amortization Of Intangible Assets | 166000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 26000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 44365000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Common Stock Shares Outstanding | 65926000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Finite Lived Intangible Assets Net | 1054000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | General And Administrative Expense | 3332000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | Adjusted general and administrative includes compensation costs and fees paid to consultants and outside service providers and organizations in support of the administrative functions of the Company, including finance, legal and human resources. | |
| 0001437749-25-015565 | 20250331 | General And Administrative Expense | 3791000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -7000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Interest Income Expense Nonoperating Net | 1249000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Inventory Net | 30000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Liabilities Current | 10055000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Liabilities Current | 7760000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Cash Provided By Used In Operating Activities | -13521000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Income Loss | -10137000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Net Income Loss | -16795000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20240331 | Nonoperating Income Expense | -478000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20250331 | Operating Lease Liability Noncurrent | 7171000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241031 | Operating Lease Right Of Use Asset | 800000.0000 | USD | 0 | us-gaap/2025 | Lease Contractual Term= Miami Lease; | ||
| 0001437749-25-015565 | 20241231 | Other Assets Noncurrent | 677000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Payments To Acquire Property Plant And Equipment | 45000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Prepaid Expense And Other Assets Current | 1411000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Proceeds From Warrant Exercises | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Proceeds From Warrant Exercises | 14075000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20231231 | Stockholders Equity | 44360000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Stockholders Equity | -390500000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 26000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 1 | us-gaap/2025 | Award Type= Performancebased And Marketbased Options; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 51000.0000 | shares | 1 | us-gaap/2025 | Award Type= Timebased Options; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 51000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 296000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Exercise Of Warrants | 13972000.0000 | USD | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 9000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 1241000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-015565 | 20240331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Subsidiary Sale Of Stock= The2024 Right Offering; | ||
| 0001437749-25-015565 | 20240630 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Subsidiary Sale Of Stock= The2024 Right Offering; | ||
| 0001437749-25-015565 | 20250331 | Common Stock Shares Outstanding | 67274000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Costs And Expenses | 18044000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Accrued Liabilities | -1546000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Operating Lease Right Of Use Asset | -274000.0000 | USD | 1 | 0001437749-25-015565 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Other Noncurrent Assets | 1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Other Receivables | 7000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Income Loss | -16795000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Operating Income Loss | -18044000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Proceeds From Stock Plans | 296000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Proceeds From Warrant Exercises | 63500000.0000 | USD | 4 | us-gaap/2025 | Class Of Warrant Or Right= Warrants Issued In2024 Rights Offering; | ||
| 0001437749-25-015565 | 20241231 | Property Plant And Equipment Net | 1160000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20231231 | Stockholders Equity | 381220000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20240331 | Stockholders Equity | -347052000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Stockholders Equity | 525680000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Stockholders Equity | 67000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 78000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Exercise Of Warrants | 1271000.0000 | shares | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Exercise Of Warrants | 0.0000 | USD | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 67126000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Accrued Liabilities Current | 3984000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20241231 | Assets | 132460000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Assets Current | 120909000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Cash And Cash Equivalents At Carrying Value | 119279000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-015565 | 20241231 | Common Stock Shares Issued | 65926000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Costs And Expenses | 10615000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Inventories | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Nonoperating Income Expense | -1249000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20240331 | Operating Income Loss | -10615000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Other Assets Noncurrent | 678000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Prepaid Expense And Other Assets Current | 1600000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Research And Development Expense | 10313000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Retained Earnings Accumulated Deficit | -407295000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Shares Outstanding | 67274000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20240331 | Stockholders Equity | 55000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20241231 | Stockholders Equity | 66000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 25844.0000 | shares | 1 | us-gaap/2025 | Plan Name= The2017 Employee Stock Purchase Plan; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 1 | us-gaap/2025 | Award Type= Performance Options; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20240331 | Warrant Issuance Costs In Accounts Payable | 0.0000 | USD | 1 | 0001437749-25-015565 | |||
| 0001437749-25-015565 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1759000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Amortization Of Intangible Assets | 167000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 34885000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 118038000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -16795000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Accrued Liabilities | -3043000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Other Noncurrent Assets | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Liabilities | 17598000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Cash Provided By Used In Investing Activities | -5000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Cash Provided By Used In Operating Activities | -9780000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20241231 | Operating Lease Liability Current | 1355000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Operating Lease Right Of Use Asset | 6889000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Proceeds From Stock Plans | 352000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Retained Earnings Accumulated Deficit | -390500000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Share Based Compensation | 5681000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Warrant Issuance Costs In Accounts Payable | 11000.0000 | USD | 1 | 0001437749-25-015565 | |||
| 0001437749-25-015565 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 57124000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Common Stock Value | 66000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Earnings Per Share Basic | -0.1800 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Finite Lived Intangible Assets Net | 1220000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | General And Administrative Expense | 7731000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Goodwill | 2791000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10137000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Accounts Payable | 712000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Other Receivables | 7000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 274000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Inventory Net | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Liabilities And Stockholders Equity | 132460000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20240331 | Nonoperating Income Expense | 478000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Operating Lease Liability Current | 1406000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Operating Lease Liability Noncurrent | 7543000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Proceeds From Stock Options Exercised | 380000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Stockholders Equity | 36287000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Stockholders Equity | 114862000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 352000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20241231 | Accounts Payable Current | 1673000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Common Stock Value | 67000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Depreciation | 132000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Earnings Per Share Basic | -0.2500 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | General And Administrative Expense | 3874000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20141231 | Goodwill | 2800000.0000 | USD | 0 | us-gaap/2025 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; | ||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Accounts Payable | -124000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Operating Lease Liability | -321000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Cash Provided By Used In Financing Activities | 305000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Cash Provided By Used In Financing Activities | 14807000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Nonoperating Income Expense | 1249000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Stockholders Equity | 383284000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Stockholders Equity | 118452000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Stockholders Equity | -407295000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Exercise Of Warrants | 1000.0000 | USD | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Exercise Of Warrants | 0.0000 | USD | 1 | 0001437749-25-015565 | Class Of Warrant Or Right= Rights Offering Warrants; Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20240331 | Research And Development Expense | 6741000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Accrued Liabilities Current | 7027000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Additional Paid In Capital Common Stock | 525680000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015565 | 20241231 | Assets Current | 119449000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20241231 | Cash And Cash Equivalents At Carrying Value | 118038000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Comprehensive Income Net Of Tax | -16795000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Depreciation | 117000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Increase Decrease In Inventories | 30000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Increase Decrease In Operating Lease Liability | -247000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Interest Income Expense Nonoperating Net | 478000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Liabilities And Stockholders Equity | 133383000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Net Cash Provided By Used In Investing Activities | -45000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20240331 | Net Income Loss | -10137000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Operating Segments; | ||
| 0001437749-25-015565 | 20240331 | Shares Outstanding | 55225000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20231231 | Stockholders Equity | -336915000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015565 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 3000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 51000.0000 | shares | 1 | us-gaap/2025 | Plan Name= The2015 Plan2017 Plan And Inducement Plan; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 352000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 380000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 380000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015565 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Value Exercise Of Warrants | 0001437749-25-015565 | 1 | 0 | monetary | D | C | Issuance of common stock pursuant to warrant exercise | Value of stock issued during the period for the exercise of warrants. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Operating Lease Right Of Use Asset | 0001437749-25-015565 | 1 | 0 | monetary | D | C | plse_IncreaseDecreaseInOperatingLeaseRightOfUseAsset | Amount of increase (decrease) in operating lease right of use asset. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Warrant Issuance Costs In Accounts Payable | 0001437749-25-015565 | 1 | 0 | monetary | D | C | Warrant issuance costs in accounts payable | Amount of warrant issuance costs in accounts payable in noncash transaction. |
| Finite Lived Intangible Assets Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Amortization Of Intangible Assets | us-gaap/2025 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Depreciation | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Interest Income Expense Nonoperating Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Stock Plans | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. |
| Increase Decrease In Inventories | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Costs And Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Warrant Exercises | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Shares Exercise Of Warrants | 0001437749-25-015565 | 1 | 0 | shares | D | Issuance of common stock pursuant to warrant exercise (in shares) | Number of shares issued during the period for the exercise of warrants. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Goodwill | us-gaap/2025 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Increase Decrease In Other Receivables | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Receivables | Amount of increase (decrease) in receivables classified as other. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Inventory Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Proceeds From Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-015565 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001437749-25-015565 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2025 | Inventory | 0 |
| 0001437749-25-015565 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001437749-25-015565 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001437749-25-015565 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001437749-25-015565 | 2 | 9 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2025 | Intangible assets, net | 0 |
| 0001437749-25-015565 | 2 | 10 | BS | 0 | H | Goodwill | us-gaap/2025 | Goodwill | 0 |
| 0001437749-25-015565 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Right-of-use assets | 0 |
| 0001437749-25-015565 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other assets | 0 |
| 0001437749-25-015565 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001437749-25-015565 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001437749-25-015565 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001437749-25-015565 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Lease liability, current | 0 |
| 0001437749-25-015565 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001437749-25-015565 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Lease liability, less current portion | 0 |
| 0001437749-25-015565 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001437749-25-015565 | 2 | 21 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and contingencies (Note 7) | 0 |
| 0001437749-25-015565 | 2 | 23 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock, $0.001 par value; authorized 50,000 shares; no shares issued and outstanding | 0 |
| 0001437749-25-015565 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.001 par value; authorized 500,000 shares; issued and outstanding 67,274 shares and 65,926 shares at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001437749-25-015565 | 2 | 25 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001437749-25-015565 | 2 | 26 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive income (loss) | 0 |
| 0001437749-25-015565 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001437749-25-015565 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001437749-25-015565 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001437749-25-015565 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in dollars per share) | 0 |
| 0001437749-25-015565 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized (in shares) | 0 |
| 0001437749-25-015565 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued (in shares) | 0 |
| 0001437749-25-015565 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001437749-25-015565 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
| 0001437749-25-015565 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized (in shares) | 0 |
| 0001437749-25-015565 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued (in shares) | 0 |
| 0001437749-25-015565 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding (in shares) | 0 |
| 0001437749-25-015565 | 4 | 4 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | Total revenues | 0 |
| 0001437749-25-015565 | 4 | 6 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001437749-25-015565 | 4 | 7 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001437749-25-015565 | 4 | 8 | IS | 0 | H | Costs And Expenses | us-gaap/2025 | Total cost and expenses | 0 |
| 0001437749-25-015565 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001437749-25-015565 | 4 | 11 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2025 | Interest income, net | 0 |
| 0001437749-25-015565 | 4 | 12 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income | 0 |
| 0001437749-25-015565 | 4 | 13 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss from operations, before income taxes | 0 |
| 0001437749-25-015565 | 4 | 14 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Income tax benefit | 0 |
| 0001437749-25-015565 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015565 | 4 | 16 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss | 0 |
| 0001437749-25-015565 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic and diluted net loss per share (in dollars per share) | 0 |
| 0001437749-25-015565 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average shares used to compute net loss per common share basic and diluted (in shares) | 0 |
| 0001437749-25-015565 | 5 | 4 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015565 | 5 | 6 | CF | 0 | H | Depreciation | us-gaap/2025 | Depreciation | 0 |
| 0001437749-25-015565 | 5 | 7 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2025 | Amortization of intangible assets | 0 |
| 0001437749-25-015565 | 5 | 8 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
| 0001437749-25-015565 | 5 | 10 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2025 | Inventory | 1 |
| 0001437749-25-015565 | 5 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001437749-25-015565 | 5 | 12 | CF | 0 | H | Increase Decrease In Other Receivables | us-gaap/2025 | Other receivables | 1 |
| 0001437749-25-015565 | 5 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Right Of Use Asset | 0001437749-25-015565 | Right-of-use assets | 1 |
| 0001437749-25-015565 | 5 | 14 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | Other long-term assets | 1 |
| 0001437749-25-015565 | 5 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001437749-25-015565 | 5 | 16 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001437749-25-015565 | 5 | 17 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Lease liabilities | 0 |
| 0001437749-25-015565 | 5 | 18 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001437749-25-015565 | 5 | 20 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
| 0001437749-25-015565 | 5 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
| 0001437749-25-015565 | 5 | 23 | CF | 0 | H | Proceeds From Stock Plans | us-gaap/2025 | Proceeds from issuance of common stock under employee stock purchase plan | 0 |
| 0001437749-25-015565 | 5 | 24 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2025 | Proceeds from exercises of warrants | 0 |
| 0001437749-25-015565 | 5 | 25 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2025 | Proceeds from exercises of stock options | 0 |
| 0001437749-25-015565 | 5 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001437749-25-015565 | 5 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0001437749-25-015565 | 5 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents at beginning of period | 0 |
| 0001437749-25-015565 | 5 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents at end of period | 0 |
| 0001437749-25-015565 | 5 | 31 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | Equipment purchases included in accounts payable | 1 |
| 0001437749-25-015565 | 5 | 32 | CF | 0 | H | Warrant Issuance Costs In Accounts Payable | 0001437749-25-015565 | Warrant issuance costs in accounts payable | 0 |
| 0001437749-25-015565 | 6 | 12 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001437749-25-015565 | 6 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-015565 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Shares Exercise Of Warrants | 0001437749-25-015565 | Issuance of common stock pursuant to warrant exercise (in shares) | 0 |
| 0001437749-25-015565 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Value Exercise Of Warrants | 0001437749-25-015565 | Issuance of common stock pursuant to warrant exercise | 0 |
| 0001437749-25-015565 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | Issuance of common stock upon exercise of stock options (in shares) | 0 |
| 0001437749-25-015565 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | Issuance of common stock upon exercise of stock options | 0 |
| 0001437749-25-015565 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2025 | Issuance of common stock under employee stock purchase plan (in shares) | 0 |
| 0001437749-25-015565 | 6 | 19 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2025 | Issuance of common stock under employee stock purchase plan | 0 |
| 0001437749-25-015565 | 6 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001437749-25-015565 | 6 | 21 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015565 | 6 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001437749-25-015565 | 6 | 23 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-015565 | 7 | 6 | EQ | 1 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | Issuance cost | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |